Shiwu Wu

1.1k total citations
61 papers, 871 citations indexed

About

Shiwu Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shiwu Wu has authored 61 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 31 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Shiwu Wu's work include Cancer Cells and Metastasis (20 papers), Angiogenesis and VEGF in Cancer (12 papers) and Cell Adhesion Molecules Research (12 papers). Shiwu Wu is often cited by papers focused on Cancer Cells and Metastasis (20 papers), Angiogenesis and VEGF in Cancer (12 papers) and Cell Adhesion Molecules Research (12 papers). Shiwu Wu collaborates with scholars based in China and United States. Shiwu Wu's co-authors include Wenqing Song, Lei Zhou, Lan Yu, Danna Wang, Xiaomeng Gong, Yisheng Tao, Bo Zhu, Cheng Ze-nong, Damin Chai and Li Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Neurophysiology.

In The Last Decade

Shiwu Wu

60 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiwu Wu China 19 546 353 303 195 96 61 871
Anna G. Antonacopoulou Greece 21 529 1.0× 457 1.3× 257 0.8× 138 0.7× 73 0.8× 50 1.0k
Paraskevi Alexandrou Greece 18 497 0.9× 390 1.1× 280 0.9× 82 0.4× 56 0.6× 43 922
Tieju Liu China 20 764 1.4× 340 1.0× 451 1.5× 133 0.7× 55 0.6× 38 1.0k
Yangfan Lv China 16 583 1.1× 205 0.6× 359 1.2× 130 0.7× 86 0.9× 31 892
Giovanni D’Ario Italy 10 661 1.2× 431 1.2× 245 0.8× 125 0.6× 199 2.1× 15 1.0k
Shi Chang United States 7 484 0.9× 261 0.7× 205 0.7× 404 2.1× 52 0.5× 9 904
Fang Zhu China 14 428 0.8× 214 0.6× 251 0.8× 112 0.6× 86 0.9× 41 692
Sylvia Julien France 4 521 1.0× 372 1.1× 225 0.7× 76 0.4× 57 0.6× 5 796
Dawn Steele United Kingdom 8 398 0.7× 410 1.2× 256 0.8× 101 0.5× 127 1.3× 8 761

Countries citing papers authored by Shiwu Wu

Since Specialization
Citations

This map shows the geographic impact of Shiwu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiwu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiwu Wu more than expected).

Fields of papers citing papers by Shiwu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiwu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiwu Wu. The network helps show where Shiwu Wu may publish in the future.

Co-authorship network of co-authors of Shiwu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shiwu Wu. A scholar is included among the top collaborators of Shiwu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiwu Wu. Shiwu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wenjuan, Xueying Zhang, Fan Shi, et al.. (2024). Expression and potential molecular mechanism of TOP2A in metastasis of non-small cell lung cancer. Scientific Reports. 14(1). 12228–12228. 9 indexed citations
2.
Li, Wenjuan, Li Fan, Linxiang Zhang, et al.. (2024). PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT. BMC Cancer. 24(1). 633–633. 4 indexed citations
3.
Shi, Fan, Shujun Guo, Yao Li, et al.. (2023). LINC02086 promotes cell viability and inhibits cell apoptosis in breast cancer by sponging miR-6757-5p and up-regulating EPHA2. World Journal of Surgical Oncology. 21(1). 371–371. 6 indexed citations
4.
Zhang, Lei, et al.. (2023). The role of TOP2A in immunotherapy and vasculogenic mimicry in non-small cell lung cancer and its potential mechanism. Scientific Reports. 13(1). 10906–10906. 15 indexed citations
5.
Cheng, Lili, Qi Wang, Qiong Wu, et al.. (2020). FOXM 1 induces Vasculogenic mimicry in esophageal cancer through β-catenin /Tcf4 signaling. Diagnostic Pathology. 15(1). 14–14. 9 indexed citations
6.
Chai, Damin, Shiwu Wu, Li Ma, et al.. (2019). WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 102–102. 20 indexed citations
7.
Wang, Qi, et al.. (2019). The Emerging Role of Sperm-Associated Antigen 6 Gene in the Microtubule Function of Cells and Cancer. Molecular Therapy — Oncolytics. 15. 101–107. 19 indexed citations
8.
Zhu, Bo, Yichao Wang, Xiaolin Wang, et al.. (2018). Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma. Diagnostic Pathology. 13(1). 45–45. 19 indexed citations
9.
Yu, Lan, Bo Zhu, Shiwu Wu, et al.. (2017). Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma. Diagnostic Pathology. 12(1). 23–23. 53 indexed citations
10.
Zhang, Qiong, et al.. (2017). Down-regulation of ASIC1 suppressed gastric cancer via inhibiting autophagy. Gene. 608. 79–85. 22 indexed citations
11.
Song, Wenqing, et al.. (2016). Correlation between expression of ALDH1 /ABCG2 and microvessel formation in epithelial ovarian cancer. 32(10). 1814. 1 indexed citations
12.
Zhou, Lei, Lan Yu, Bo Zhu, et al.. (2016). Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer. BMC Cancer. 16(1). 876–876. 34 indexed citations
13.
Li, Nan, et al.. (2016). Extrapancreatic solid pseudopapillary tumors: A clinicopathological analysis of two cases. Molecular and Clinical Oncology. 4(5). 845–850. 13 indexed citations
14.
Gong, Xiaomeng, Yisheng Tao, Yu Lan, et al.. (2015). [Expressions of Snail, Slug and KAI1 proteins in cervical carcinoma and their clinicopathological significance].. PubMed. 35(12). 1733–8. 4 indexed citations
15.
16.
Han, Xiao, et al.. (2015). Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24. International Immunopharmacology. 29(2). 416–422. 37 indexed citations
17.
Zhou, Lei, Lan Yu, Xiaomeng Gong, et al.. (2015). Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry. Asian Pacific Journal of Cancer Prevention. 16(10). 4177–4183. 13 indexed citations
19.
Yu, Lan, Lei Zhou, Shiwu Wu, et al.. (2014). Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma. World Journal of Surgical Oncology. 12(1). 118–118. 23 indexed citations
20.
Wu, Shiwu, Lan Yu, Cheng Ze-nong, et al.. (2012). Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(3). 346–352. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026